This randomised double-blind, placebo-controlled study showed that administration of 6 mg/day melatonin for 12 weeks improved a number of factors associated with NAFLD, such as enzymes (aspartate aminotransferase, AST; alanine aminotransferase, ALT), anthropometric factors (weight, waist circumference, abdominal circumference), blood pressure, serum leptin levels, and the grade of fatty liver. Here, GPT is linked to fatty liver disease.